Asia Regional Meeting on
Interventions for Impact in Essential Obstetric and Newborn Care Draft Agenda Dates:
4–6 May 2012 (Opening Ceremony and Reception on 3 May)
Location:
Dhaka, Bangladesh (Ruposhi Bangla Hotel, Dhaka)
Organizers:
Organized by the Government of Bangladesh, USAID’s flagship Maternal, Newborn and Child Health Integrated Program (MCHIP), and the Bill & Melinda Gates Foundationsupported Oxytocin Initiative, with support from Women Deliver and VSI and in collaboration with FIGO and ICM.
Description:
This meeting will bring together maternal/newborn health leaders, experienced clinicians and program managers to support accelerated implementation and expansion of maternal and newborn health programs in countries in Asia and the Middle East. The meeting will focus on postpartum hemorrhage (PPH), pre-eclampsia/eclampsia (PE/E) and other aspects of maternal and newborn health. The first day will include an overview of global and regional progress to date in the reduction of maternal mortality and an update on new global guidelines for PPH. It will engage participants in a technical discussion on PPH prevention and treatment, including a review of issues related to quality and availability of uterotonics and maternal health supplies. The second and third days will allow time to deliberate on management of pre-eclampsia and review PE/E program implementation experience, as well as interventions for newborns. The entire afternoon of the second day will be devoted to skill building sessions and opportunities to explore more deeply some technical issues related to service delivery and training. True to the global perspective, the meeting will emphasize PPH, PE/E and newborn initiatives from the platform of essential obstetric and newborn care and discuss it with respect to the broader maternal and newborn health context in general, exploring themes of innovation, scale-up and measurement.
Meeting Objectives:
To present and discuss global scientific and technical information on prevention, early detection and management of PPH and PE/E, and special care for newborns
To review/discuss programmatic experiences and progress in the implementation of newborn care and PPH prevention/management programs in Asia/the Middle East
To review and consider an appropriate programmatic platform for the scale-up of PPH reduction and newborn care programs and the initiation or expansion of PE/E reduction programs that can be implemented at multiple levels of the health system
To develop knowledge and greater understanding of selected interventions in maternal and newborn health
Audience:
Ministries of Health from governments throughout Asia and the Middle East, predominantly from maternal and newborn health units
Professional societies of midwifery, obstetrics and pediatrics; universities and pre-service education institutions
Leading Asian institutions working in maternal and newborn health
Global health agencies: WHO, UNICEF, UNFPA, World Bank
Donors and USAID Missions from throughout Asia and the Middle East
Implementing partners, bilateral programs in MNH, MCHIP implementing partners
Collaborating Organizations:
USAID and the USAID/Asia Near East Bureau
The Government of Bangladesh
MCHIP
The Gates Foundation-funded Oxytocin Initiative
WHO/EMRO, WHO/SEARO and WHO/WPRO, UNICEF, UNFPA
FIGO, ICM, FCI, Women Deliver
Participants from: 1. 2. 3. 4. 5. 6. 7. 8. 9. 10.
Bangladesh Afghanistan Pakistan India Nepal Myanmar Lao PDR Cambodia Vietnam Indonesia
11. 12. 13. 14. 15. 16. 17. 18. 19.
East Timor Philippines Papua New Guinea West Bank/Gaza Yemen Jordan Iraq Egypt All interested participants from the Middle East and Asia/Pacific Regions
Tentative Agenda: DAY BEFORE CONFERENCE ALL DAY (9:00–5:00) Special Pre-Conference Meeting on Nutritional Issues in Maternal and Newborn Health: Calcium for Prevention of Pre-Eclampsia and Iron for Treatment/Prevention of Anemia Afternoon (3:30–6:00) Pre-Conference Orientation on Programming the Helping Babies Breathe Initiative for Newborn Resuscitation Evening (7:00) Opening Ceremony Technical presentation: Maternal mortality reduction in Bangladesh (Minister of Health) Welcome: Prime Minister of Bangladesh (tentative) Welcome Dinner
2|Page
DRAFT
9 February 2012
DAY 1 Morning Improvements in Maternal Health: The Changing Situation of MNH
Maternal mortality 1990–2011: Dr. Monir Islam, WHO/SEARO
Recent documented reductions in maternal mortality in Asia—Four stories: - Bangladesh: TBD - Afghanistan: Honorable Dr. Suraya Dalil, Minister of Health - Nepal: Dr. Pradhan, Director General, Ministry of Health - Cambodia: His Excellency Deputy Prime Minister Yin Chhay Ly
Determinants of Maternal Health in Asia: Bushra Alam, World Bank, Dhaka
Global Evidence and Guidance for PPH Prevention and Treatment
WHO PPH and task shifting guidance: João Paulo de Souza, WHO
AMTSL trial: TBD
The evidence for use of misoprostol for prevention and treatment of PPH: Rasha Dabash, Gynuity
Prevention and management strategies at levels of health system: Farhana Dewan, OGSB
Lunch and Prayers Afternoon Overcoming Barriers and Measuring Success—Implementing PPH Prevention and Management Programs
Global overview of PPH scale-up: A multi-country analysis: Jeffrey Smith, MCHIP
Maternal health indicators and use of a uterotonic in 3rd stage: Steve Hodgins, MCHIP
Experience with community level use of misoprostol in Asia: Ndola Prata, VSI
Implementation experience: Bangladesh (highlight operational issues): Bangladesh Rep
Implementation experience: Nepal (highlight national scale-up process): Naresh Pratap KC, FHD, Government of Nepal
Drugs and Commodities
Quality of oxytocin and ergometrine, India scoping exercise: Cindy Stanton, OI and JHU
Quality of misoprostol: Peter Hall, Concept Foundation
Improving the quality of uterotonics: Patrick Lukulay, USP
The horizons of oxytocin—TTIs, heat stable oxytocin: Hans Hogerzeil, ex-WHO
GROUP EXERCISE: Uterotonic Selection Tool Optional Evening Satellites
Story of Bangladesh maternal mortality reduction: MOH/Bangladesh
Uterotonic use in India: Oxytocin Initiative
Training on PPH Prevention–“Bleeding After Birth”: Peter Johnson, Cherrie Evans , Jhpiego
Improving newborn survival: Role of chlorhexidine application to the umbilical stump: Esther Lwanga, USAID
Improving newborn survival through structured home visits: Neena Khadkha, Save the Children International
Maternal health supplies working group—A landscape analysis: TBD
3|Page
DRAFT
9 February 2012
DAY 2 Morning Opening of the Day and Daily Keynote: Quality of care/ Access to care: Lynn Freedman, AMDD Evidence for Prevention and Detection of PE/E
New WHO guidelines on PE/E (2011): João Paulo de Souza, WHO
Use of calcium and Vitamin D for prevention: Zulfi Bhutta, Aga Khan Univ, Karachi
Detection of PE during ANC—Data from QoC studies: Barbara Rawlins, MCHIP
Screening and early detection of PE/E at community: Harshad Sanghvi, Jhpiego
Evidence for Decisions in PE/E Management
Choice of anticonvulsants in treatment of PE/E: João Paulo de Souza, WHO
Choice of antihypertensives in treatment of PE/E: Tabassum Firoz, Pre-EMPT
Induction of labor/delivery management in PE/E: Narimah Awin, WHO/SEARO
Management strategies at different levels of health system: Dwirani Amelia, Jhpiego/Indonesia
Lunch Afternoon—Need most of afternoon for these sessions. Programs for PE/E
MgSO4 in Bangladesh: OGSB
Calcium supplementation Nepal: Kusum Thapa/Nepal
Experience implementing PE/E management program in Nigeria: Pop Council, Nigeria
Does literature support perception that MgSO4 is a dangerous drug? MCHIP/VSI
Skills Sessions (Total 8 offerings, participant chooses 4): 1. BP measurement/Urine testing 2. Induction of labor 3. MgSO4 teaching tool 4. New PPH technologies (tamponade, condom catheter, anti-shock garment, non-invasive anemia testing) 5. Essential newborn care 6. Kangaroo mother care 7. MamaNatalie 8. Oxytocin in Uniject Poster Session: Status of PPH and PE/E Programs in Participating Countries Optional Evening Satellites 1. mHealth and the MAMA Initiative: James Bon Tempo 2. PPH, PE/E, PPFP and PSE toolkits: Catherine Carr, Stephanie Suhowatsky 3. Improving newborn resuscitation using HBB materials for interested countries: Ishtiaq Mannan, MCHIP/Bangladesh 4. Integration of FP and MNH—Health approach: Cat McKaig 5. MNH financing strategies
4|Page
DRAFT
9 February 2012
DAY 3 Morning Opening of the Day and Opening Plenary: Sue Bree, ICM
SoWMy Report/Midwifery in Asia: Prakassama, Indian Midwifery Association
Midwifery model in Afghanistan: Pashtoon Azfar, ICM
Scaling up HRH for MNH through the HBCI: Petra ten Hoope-Bender, Integrare
Newborn Panel/Interventions for Newborn Complications ( Lily Kak, USAID/Washington)
Technical update on newborn resuscitation and home visits for newborn survival: WHO Representative
Improving newborn resuscitation in Bangladesh: Mohammod Shahidullah, BSMMU
Ensuring newborns with infections get prompt treatment: Shyam Upretti, MOH Nepal
Scaling-up kangaroo mother care in Vietnam: Dinh Thi Phuong Hoa, MOH/Vietnam
Addressing Other Areas of Maternal Health
Maternal sepsis
Complications of unsafe abortion
Integration of FP and MNH programs: Abdullah Baqui, JHU
Lunch Afternoon GROUP EXERCISE: Interventions for Prevention and Management of PPH Interventions for Prevention and Management of Pre-Eclampsia/Eclampsia Country Posters (meeting by country group) Implementation MNH Programs
Financial incentives for use of MNH services—A USAID evidence summit; and new universal rights of childbearing women: Remarks from Mary Ellen Stanton
Respectful care at birth: Baharuddin, Budi Kemuliaan Hospital, Jakarta
MNH financing I: Equity Fund-Cambodia: Cambodia
MNH financing II: JS-India: Ministry of Health and Family Welfare, India
Environment for MNH
Health system for MNH: Ana Langer, MHTF
Advocacy for MNH: Ann Starrs, FCI
The role of maternal health professionals in reducing MMR: Andre Lalonde, FIGO
Going beyond MDGs and 2015: Jill Sheffield, Women Deliver
Panel Discussion: The Way Forward: Integrating New Ideas and Approaches with Current Situations in Countries Summary and Closing
5|Page
DRAFT
9 February 2012